SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-14-000024
Filing Date
2014-05-06
Accepted
2014-05-06 16:52:00
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20140331x10q.htm 10-Q 755009
2 EXHIBIT gale-20140331xex101.htm EX-10.1 89765
3 EXHIBIT gale-20140331xex311.htm EX-31.1 8175
4 EXHIBIT gale-20140331xex312.htm EX-31.2 8206
5 EXHIBIT gale-20140331xex321.htm EX-32.1 6900
  Complete submission text file 0001390478-14-000024.txt   6327104

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gale-20140331.xml EX-101.INS 930659
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20140331.xsd EX-101.SCH 46746
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20140331_cal.xml EX-101.CAL 63880
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20140331_def.xml EX-101.DEF 148778
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20140331_lab.xml EX-101.LAB 552495
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20140331_pre.xml EX-101.PRE 302454
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 14817783
SIC: 2834 Pharmaceutical Preparations